Please find all related articles below.
Brussels, 23 January 2014 — Today, the Irish parliament, the Oireachtas, launched a consultation on a draft public health bill that introduces standardised tobacco packaging. If the bill passes, Ireland will become the first EU Member State—the second country in the world after Australia—to ban branding from tobacco product packaging.
The European Public Health Alliance (EPHA) has sent (1) an open letter to the Oireachtas’ Chair of the Committee on Health and (...)
The European Institute of Women’s Health (EIWH) invites its members, friends and colleagues to join them in celebrating the 8th Annual European Cervical Cancer Prevention Weekraising awareness of this uniquely preventable cancer, the second most common cancer worldwide in women under the age of forty-four.
In the EU, 31,300 women develop and 13,600 die from cervical cancer annually with higher rates in new Member States. On average, there are 175,000 women living with cervical cancer (...)
Please register before 15/11/2013 with email@example.com. If you don’t have access to the European Parliament (EP), please send us your name, date of birth, nationality and passport or ID number.
Doctors of the World / Médecins du monde (MdM)
Look at the MdM report: Access to healthcare in Europe in times of crisis and rising xenophobia
EuroChild Platform for International Cooperation on Undocumented Migrants (PICUM)
Invitation flyer (...)
A two-month public consultation (15 April to 15 June 2013) on the World Medical Association’s Declaration of Helsinki on medical research involving human subjects has been launched by the World Medical Association. A revised version of the Declaration is available on the WMA website. This consultation is of particular interest in the context of the ongoing revision of the Clinical Trials legislation.
Please click here for detailed information on the consultation process
The seminar hosted by Christel Schaldemose (S & D, DK) focused on men’s health as a vital public health issue. Health Commissioner Tonio Borg highlighted the importance of reducing health inequalities and explained how the Commission takes into account the gender dimension within its policies to improve men’s health. He stressed that prevention of diseases is much more cost effective than the cure.
The résumé of the event is available here
On 25 (...)
On the occasion of the European Cervical Cancer Prevention Week, the European Institute of Women’s Health (EIWH), an EPHA member, presented its policy brief "Women and cervical cancer in the EU: promoting cervical cancer prevention" emphasising the need to reach a consensus across the European Union to put an end to the existing disparities between Member States.
With 31 300 women developing the disease and 13 600 dying of it every year in the EU, cervical cancer remains the second (...)
14 February - Valentine’s Day is a good opportunity to think about women’s hearts. On its latest policy briefing, the European Institute of Women’s Health (EIWH) highlighted the key differences between women and men in matters of the heart - such as risk factors, symptoms, treatment and biomedical research.
Traditionally regarded as a male disease, cardiovascular disease (CVD) is the number one killer of women worldwide. It is also a major cause of serious illness and (...)
Hosted by the European Policy Centre (EPC), this EPC’s Coalition for Health, Ethics and Society (CHES) roundtable on the revision of the Clinical Trials legislation provided an opportunity for EPHA to present its Position on the policy dossier and exchange views with stakeholders including representatives of the European Commission, industry and an NGO representing older people.
The roundtable was kicked off by Stefano Soro, Head of unit for Medicinal Products – quality, safety (...)
The Council of the European Union adopted its conclusions on Violence Against Women at its 3206th Employment, Social Policy, Health and Consumer affairs (EPSCO) Council meeting on 6 December 2012. The council calls to consider 2015 as the European Year on Zero Tolerance for Violence against Women.
Considering the fact that violence against women affects society as a whole, the Council adopted a few conclusions to tackle the problem.
There is NO justification whatsoever for violence (...)
EPHA has revised its position on clinical trials following the European Commission’s release of a legislative proposal for a regulation over the summer. While the key elements remain the same, the updated version emphasises the need for clinical trials to go ahead so that different population groups can benefit from life-saving treatments, while underlining that patient safety must remain at the centre of the process, and not compromised by less rigid assessment procedures.
Ageing and Older People
Access to Medicines
Pharmaceuticals and Medicines